Sheel Biotech MD, chairman, board of directors and AGM
NSE: SHEELCommercial Services & Supplies
Share price at the NSE close on 23 Oct 2026. Previous close ₹60.05.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹120 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 May 2026
- 10.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 28 May 2026
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,000100.0% delivered
Sheel Biotech board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Sheel Biotech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sheel Biotech share news and announcements
Annual general meeting, 24 Sep 2026
392 shareholders on the register on 17 Sep 2026; present: 16 promoters and 6 others; votes counted by Gulista Saifi / GULISTA & ASSOCIATES.The company's voting result (opens in a new tab)
- Adoption of Financial Statements for FY-2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.21% · promoters 92.82% · institutions 0.00% · other public 32.82%
- Re-appointment of the retiring DirectorOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.21% · promoters 92.82% · institutions 0.00% · other public 32.82%
- Approval for Sale, Transfer and Disposal of Land and Immovable PropertySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.21% · promoters 92.82% · institutions 0.00% · other public 32.82%
- Approval of Material Related Party Transactions for the financial year 2026-27.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.21% · promoters 92.82% · institutions 0.00% · other public 32.82%
- Approval of Managerial RemunerationSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.21% · promoters 92.82% · institutions 0.00% · other public 32.82%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesOct 2025, checked by Care Rating | 34.02 | Funding capital expenditure requirements | 9.12 | 6.66 | No |
| Public IssuesOct 2025, checked by Care Rating | 34.02 | Working Capital Requirements | 15.88 | 15.88 | No |
| Public IssuesOct 2025, checked by Care Rating | 34.02 | General Corporate Purposes | 4.77 | 4.72 | No |
| Public IssuesOct 2025, checked by Care Rating | 34.02 | Issue Related Expenses | 4.25 | 4.02 | No |